In Petition, Pfizer Takes Aim At Patented Propylene-Glycol Formulation

(July 24, 2020, 11:05 AM EDT) -- ALEXANDRIA, Va. — A Novo Nordisk patent relating to a formulation used in injection devices was "already disclosed" by prior art, Pfizer Inc. tells the Patent Trial and Appeal Board in...
To view the full article, register now.